To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The US firm has raised $400 million for its seventh fund, to focus on early stage investments in biotechnology, advanced materials and specialty semiconductors.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination